Immunization News and Research

RSS

Cell signaling in cervical cancer; gene variant impairs glycogen synthesis

The March of Dimes and seven former directors of the U.S. Centers for Disease Control and Prevention (CDC) today urged parents not to be frightened of childhood vaccines by the suggestion in an upcoming episode of the ABC-TV drama, "Eli Stone" that the mercury-based preservative thimerosal -- which is no longer used in vaccines may lead to autism.

30 Jan 2008

Polymeric nanoparticles for tumor vaccines

The quest for an effective antitumor vaccine has received a boost from the results of work aimed at developing a nanoparticle that delivers tumor antigens to the immune system cells that trigger antibody production.

16 Jan 2008

Seasonal flu levels trigger use of antiviral drugs

The Health Protection Agency has confirmed that the rate at which influenza viruses are now circulating in England has reached the point which triggers the use of antiviral drugs.

11 Jan 2008

Newer meningitis vaccine MenACWY appears safe and effective for infants

A vaccine not yet licensed in the United States produces immunity against four strains of meningococcal disease and is well tolerated when administered to infants, according to a study in the January 9/16 issue of JAMA.

9 Jan 2008

Sanofi Pasteur enters agreement eith Crucell for next-generation biologicals against rabies

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it has signed an exclusive collaboration and commercialization agreement with Crucell N.V. for Crucell's rabies monoclonal antibodies (MAbs), next-generation rabies biologicals to be used in association with rabies vaccine for post-exposure prophylaxis against this fatal disease.

4 Jan 2008

Cases of meningitis caused by herpes simplex virus set to rise

Viral meningitis is common, but many cases go unreported, say researchers in this week's BMJ.

4 Jan 2008

Authorities in the U.S. say hold back on children's Hib vaccine

Health authorities in U.S. are advising doctors to defer giving booster shots of a childhood vaccine following suspicions that production equipment may not have been properly sterilized.

20 Dec 2007

Male circumcision

Circumcision is one of the commonest surgical procedures performed on males. Opponents argue that infant circumcision can cause both physical and psychological harm, while recent evidence shows that circumcision is medically beneficial.

10 Dec 2007

Gap in health rates between socioeconomic classes unchanged

Over the past century, the United States has witnessed historic advances in public health and medicine that have contributed to improved health and a significant increase in life expectancy for all socioeconomic groups.

5 Dec 2007

HIV-infected infants respond poorly to childhood vaccination

It is known that HIV-infected children who do not receive appropriate antiretroviral drugs experience immune depression, and may become susceptible to infectious diseases that would otherwise be prevented by childhood immunization.

5 Dec 2007

Middle-aged Australians more anxious and depressed than their elderly counterparts

A study, by Dr Julian Trollor and Dr Tracy Anderson from the School of Psychiatry at UNSW, found that elderly participants (those aged 65 and above) reported a lower prevalence of psychiatric and anxiety disorders and had lower levels of psychological distress than middle-aged participants.

4 Dec 2007

Vaccinating children younger than age 2 with the pneumococcal vaccine linked to less hospitalizations

Vaccinating children younger than age 2 with the pneumococcal vaccine appears to be associated with decreased hospitalizations from pneumonia and reduced health care expenses, according to a report in the December issue of Archives of Pediatrics & Adolescent Medicine.

4 Dec 2007

Pneumococcal conjugate vaccines can improve the lives of HIV-infected children

An international team of experts has published the first comprehensive review of evidence on pneumococcal conjugate vaccination (PCV) for children with HIV infection.

29 Nov 2007

Uptake of pneumococcal conjugate vaccine among children in the 1998-2002 United States birth cohorts

Since its addition to the list of routine immunizations in 2000, one childhood vaccine has helped prevent some pneumococcal-related illness, including pneumonia and otitis media.

27 Nov 2007

Cholera can be controlled with oral vaccines

Endemic cholera, a potentially fatal diarrheal disease found in the world's most impoverished countries, could be effectively controlled by orally vaccinating half of the affected populations once every two years for only pennies per dose, according to new findings by an international team of researchers led by Ira M. Longini Jr., Ph.D., a biostatistician in the Vaccine and Infectious Disease Institute at Fred Hutchinson Cancer Research Center in Seattle. Longini and colleagues will report their findings online Nov. 27 in PLoS Medicine.

27 Nov 2007

Bill finds another $200m to beat polio

The fight against polio has had an enormous boost by way of a grant of $200m from Bill Gates and Rotary.

27 Nov 2007

Researchers transfer immune response to myeloma patient

Researchers at the University of Arkansas for Medical Sciences (UAMS) have for the first time transferred an immune response in a healthy individual to a patient with multiple myeloma, a cancer of the bone marrow, showing promise for cancer vaccination.

27 Nov 2007

New strategic relationship between PAHO and the Canadian government

The Director of the Pan American Health Organization (PAHO), Dr. Mirta Roses, and the Permanent Representative of Canada to the Organization of American States (OAS), Ambassador Graeme C. Clark, have signed a master framework document that represents an important step forward in the strategic relationship between PAHO and the Canadian government Ambassador Graeme C. Clark and Dr. Mirta Roses sign the strategic cooperation framework.

27 Nov 2007

Influenza vaccine strategies for broad global access

If an influenza pandemic occurred this year, fewer than one-fifth of the approximately 13 billion vaccine doses needed to fully vaccinate the global population would be available within six months in a best-case scenario.

21 Nov 2007